West Pharma (WST) Misses Q4 EPS by 2c
Tweet
Share
E-mailGet Alerts WST Hot Sheet
Price: $365.00 +1.67%
EPS Growth %: +13.0%
Financial Fact:
Income before income taxes: 49.3M
Today's EPS Names:
CRMT, FOMI, FLES, More
EPS Growth %: +13.0%
Financial Fact:
Income before income taxes: 49.3M
Today's EPS Names:
CRMT, FOMI, FLES, More
Join SI Premium – FREE
West Pharma (NYSE: WST) reported Q4 EPS of $0.54, $0.02 worse than the analyst estimate of $0.56. Revenue for the quarter came in at $382.3 million versus the consensus estimate of $387.31 million.
For earnings history and earnings-related data on West Pharma (WST) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Greenbrier Cos. (GBX) Reports In-Line Q3 EPS
- Franklin Covey (FC) Misses Q3 EPS by 2c, lowers Guidance
- Scorpio Tankers to redeem $200M notes, secures $90M credit facility
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
